Back to FMR LLC FMR LLC

BTAIQBTAIQ
6 quarters

Position history for FMR LLCFMR LLC's holdings in BioXcel Therapeutics, Inc.

Yes. FMR holds 90,300 shares of BTAIQ (BioXcel Therapeutics), worth $127,323, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. FMR has held BTAIQ since Q3 2025, across 4 quarterly 13F filings.

Current Value

$127,323

Current Shares

90,300

Total Value Change

+$127,301

Total Shares Change

+90,289

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
90,300
0.0%
$127,3230.0%$1.41
0
2026-Q1
Unchanged
90,300
0.0%
$121,0020.0%$1.34
0
2025-Q4
Decreased
90,300
-54.5%
$144,4800.0%$1.60
0
2025-Q3
New
198,600
-
$508,4160.0%$2.56
37
2025-Q2
Exited
0
-100.0%
$00.0%$1.81
0
2025-Q1
New
11
-
$220.0%$2.03
17

Other major holders of BTAIQ: MILLENNIUM MANAGEMENT LLC, OAKTREE CAPITAL MANAGEMENT LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used